<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li Y</submitter><funding>Dutch Digestive Health Fund</funding><funding>Pfizer</funding><pagination>1596</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12650337</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(11)</volume><pubmed_abstract>Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasing in both prevalence and severity, highlighting the need for non-invasive biomarkers to assess disease activity. Extracellular vesicles (EVs), which carry molecular cargo from their cells of origin, hold promise as accessible biomarkers. We performed proteomic profiling of plasma-derived EVs from 70 patients with MASLD to identify protein signatures associated with key histological features (steatosis, metabolic dysfunction-associated steatohepatitis (MASH), and fibrosis). These proteins were subsequently correlated with magnetic resonance (MR)-based liver imaging. Plasma EV protein profile differed between mild (S1) and advanced steatosis (S3). H4C1, OIT3, and ANPEP were elevated in S3, while CCDC25 and KLHL41 we</pubmed_abstract><journal>Biomolecules</journal><pubmed_title>Plasma Extracellular Vesicles Contain Protein Biomarkers for Capturing Stages of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Preliminary Exploratory Study.</pubmed_title><pmcid>PMC12650337</pmcid><funding_grant_id>68328655</funding_grant_id><funding_grant_id>WO 21-03</funding_grant_id><pubmed_authors>Wassenaar NPM</pubmed_authors><pubmed_authors>Dullaart RPF</pubmed_authors><pubmed_authors>Driessen S</pubmed_authors><pubmed_authors>Serna-Salas S</pubmed_authors><pubmed_authors>Blokzijl H</pubmed_authors><pubmed_authors>Zwirs D</pubmed_authors><pubmed_authors>Holleboom AG</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Houttu VAT</pubmed_authors><pubmed_authors>Moshage H</pubmed_authors><pubmed_authors>Dijk AV</pubmed_authors><pubmed_authors>Mak AL</pubmed_authors><pubmed_authors>Verheij J</pubmed_authors><pubmed_authors>Wolters JC</pubmed_authors><pubmed_authors>Son KCV</pubmed_authors><pubmed_authors>Doukas M</pubmed_authors><pubmed_authors>Witjes JJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Plasma Extracellular Vesicles Contain Protein Biomarkers for Capturing Stages of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Preliminary Exploratory Study.</name><description>Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasing in both prevalence and severity, highlighting the need for non-invasive biomarkers to assess disease activity. Extracellular vesicles (EVs), which carry molecular cargo from their cells of origin, hold promise as accessible biomarkers. We performed proteomic profiling of plasma-derived EVs from 70 patients with MASLD to identify protein signatures associated with key histological features (steatosis, metabolic dysfunction-associated steatohepatitis (MASH), and fibrosis). These proteins were subsequently correlated with magnetic resonance (MR)-based liver imaging. Plasma EV protein profile differed between mild (S1) and advanced steatosis (S3). H4C1, OIT3, and ANPEP were elevated in S3, while CCDC25 and KLHL41 we</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-05-19T03:22:34.394Z</modification><creation>2026-05-19T03:11:59.883Z</creation></dates><accession>S-EPMC12650337</accession><cross_references><pubmed>41301514</pubmed><doi>10.3390/biom15111596</doi></cross_references></HashMap>